Clinical Trials: Renal Cancer

California

Duarte; City of Hope
A Phase II Trial of Perifosine Following Tyrosine Kinase Inhibitor Failure in Patients with Advanced Renal Cell Carcinoma

Maryland

Baltimore; Johns Hopkins Unv., School of Medicine
A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies

Baltimore; Johns Hopkins Unv. School of Med., Sidney Kimmel Comprehensive Cancer Center
A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies

Michigan

Detroit; Henry Ford Health System
A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies

Missouri

St. Louis; Washington University School of Medicine - Barnes Jewish Hospital
A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies

North Carolina

Huntersville; Carolina BioOncology Institute, PLLC
A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies


Back to Clinical Trials by Medical Areas

Research centers
specializing in
this illness area

Additional resources
in this illness area

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listing updated: May 13, 2008 at 3:21:59 PM

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA